Welcome to LookChem.com Sign In|Join Free
  • or
Monomyristin, also known as 1-Monomyristin, is a 1-monoglyceride with tetradecanoyl (myristoyl) as the acyl group. It is a naturally occurring compound found in various plant sources, including Serenoa repens. Monomyristin has a role as a Caenorhabditis elegans metabolite and exhibits both antibacterial and antifungal activities.

589-68-4

Post Buying Request

589-68-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

589-68-4 Usage

Uses

Used in Pharmaceutical Industry:
Monomyristin is used as an active pharmaceutical ingredient for its antibacterial properties, particularly against several Gram-positive bacterial strains such as Staphylococcus aureus and Aggregatibacter actinomycetemcomitans. It also demonstrates antifungal activity against Candida albicans, making it a potential candidate for the development of new antibiotics and antifungal medications.
Used in Cosmetics and Personal Care Industry:
Monomyristin is used as a key ingredient in the preparation of nonionic surfactant micelles. These micelles are essential in the formulation of various cosmetics and personal care products, such as creams, lotions, and shampoos, due to their emulsifying, solubilizing, and stabilizing properties.
Used in Research and Development:
As a Caenorhabditis elegans metabolite, Monomyristin is utilized in research studies to understand its role in biological processes and its potential applications in the development of new drugs and therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 589-68-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,8 and 9 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 589-68:
(5*5)+(4*8)+(3*9)+(2*6)+(1*8)=104
104 % 10 = 4
So 589-68-4 is a valid CAS Registry Number.
InChI:InChI=1/C17H32O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-16(20)22-17(21)15(19)14-18/h15,18-19H,2-14H2,1H3

589-68-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (M1073)  Monomyristin  >97.0%(GC)

  • 589-68-4

  • 1g

  • 640.00CNY

  • Detail
  • TCI America

  • (M1073)  Monomyristin  >97.0%(GC)

  • 589-68-4

  • 5g

  • 1,990.00CNY

  • Detail
  • Sigma

  • (M1890)  rac-Glycerol 1-myristate  ≥99%

  • 589-68-4

  • M1890-100MG

  • 966.42CNY

  • Detail
  • Sigma

  • (M1890)  rac-Glycerol 1-myristate  ≥99%

  • 589-68-4

  • M1890-1G

  • 5,068.44CNY

  • Detail

589-68-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3-Dihydroxypropyl tetradecanoate

1.2 Other means of identification

Product number -
Other names Myristic acid 1-monoglyceride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:589-68-4 SDS

589-68-4Synthetic route

(2,2-dimethyl-1,3-dioxolane-4-yl)methyl myristate
56630-71-8

(2,2-dimethyl-1,3-dioxolane-4-yl)methyl myristate

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
With Amberlyst-15 In ethanol at 20℃; for 30h;100%
With hydrogenchloride In methanol for 0.166667h; Hydrolysis; Heating;
With AmberlystTM 15 In ethanol; water for 3h; Reflux;
With amberlyst-15 In methanol at 20℃; for 16h;
4-hydroxymethyl-1,3-dioxolan-2-one
931-40-8

4-hydroxymethyl-1,3-dioxolan-2-one

n-tetradecanoic acid
544-63-8

n-tetradecanoic acid

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
With triethylamine at 143 - 145℃; for 9h;90%
allyl tetradecanoate
45236-96-2

allyl tetradecanoate

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
With cethyltrimethylammonium permanganate In dichloromethane for 5h; Ambient temperature;76%
oxiranyl-methanol
556-52-5

oxiranyl-methanol

n-tetradecanoic acid
544-63-8

n-tetradecanoic acid

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
With tributyl-amine at 85℃; for 5h;62%
With tributyl-amine at 85℃; for 5h; Inert atmosphere;
With tributyl-amine
With tributyl-amine
potassium myristate
13429-27-1

potassium myristate

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

potassium myristate
13429-27-1

potassium myristate

3-monochloro-1,2-propanediol
96-24-2

3-monochloro-1,2-propanediol

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
at 180℃;
γ-chloro-propylene glycol-α-myristate

γ-chloro-propylene glycol-α-myristate

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
With silver(I) nitrite at 125 - 130℃;
tetradecanoyl chloride
112-64-1

tetradecanoyl chloride

glycerol-α.β-isopropylidene ether

glycerol-α.β-isopropylidene ether

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
With quinoline unter Eiskuehlung und Zersetzung des in Aether geloesten Glycerin-α.β-isopropylidenaether-myristats mit kalter konz.Salzsaeure oder mit 0.25 n-Schwefelsaeure bei 40grad;
n-tetradecanoic acid
544-63-8

n-tetradecanoic acid

glycerol-1.2-isopropylidene ether

glycerol-1.2-isopropylidene ether

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
With hydrogenchloride anschliessend Behandeln des Reaktionsprodukts mit konz.HCl bei 0grad; inactive form;
n-tetradecanoic acid
544-63-8

n-tetradecanoic acid

glycerol
56-81-5

glycerol

A

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

B

dimyristin and trimyristin

dimyristin and trimyristin

Conditions
ConditionsYield
at 250℃;
glycerol
56-81-5

glycerol

myristic anhydride
626-29-9

myristic anhydride

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
With Candida antarctica In 1,4-dioxane at 15℃; for 4h;13 % Chromat.
methyl myristoate
124-10-7

methyl myristoate

glycerol
56-81-5

glycerol

A

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

B

1,2-dimyristoyl-rac-glycerol
20255-94-1

1,2-dimyristoyl-rac-glycerol

C

glycerin monomyristate
3443-83-2

glycerin monomyristate

D

glycerol 1,3-dimyristate
7770-09-4

glycerol 1,3-dimyristate

Conditions
ConditionsYield
HMS-TBD In dimethyl sulfoxide at 110℃; for 3h;
n-tetradecanoic acid
544-63-8

n-tetradecanoic acid

neutral potassium myristate

neutral potassium myristate

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 4-(dimethylamino)pyridine; N,N'-dicyclohexylcarbodiimide / diethyl ether / 4.5 h / 20 - 25 °C
2: aq. HCl / methanol / 0.17 h / Heating
View Scheme
n-tetradecanoic acid
544-63-8

n-tetradecanoic acid

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: thioyl chloride / 2 h / Heating
2: 4.7 g / pyridine / 0.17 h / Ambient temperature
3: 76 percent / cetyltrimethylammonium permanganate / CH2Cl2 / 5 h / Ambient temperature
View Scheme
Multi-step reaction with 2 steps
2: quinoline / unter Eiskuehlung und Zersetzung des in Aether geloesten Glycerin-α.β-isopropylidenaether-myristats mit kalter konz.Salzsaeure oder mit 0.25 n-Schwefelsaeure bei 40grad
View Scheme
Multi-step reaction with 2 steps
1: toluene-4-sulfonic acid / toluene / Reflux
2: AmberlystTM 15 / ethanol; water / 3 h / Reflux
View Scheme
Multi-step reaction with 2 steps
1: dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride / dichloromethane / 16 h / 0 - 20 °C
2: amberlyst-15 / methanol / 16 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: sulfuric acid / 4.5 h / Sonication
2: potassium carbonate / 30 h / 139.84 °C
3: Amberlyst-15 / ethanol / 30 h / 20 °C
View Scheme
tetradecanoyl chloride
112-64-1

tetradecanoyl chloride

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 4.7 g / pyridine / 0.17 h / Ambient temperature
2: 76 percent / cetyltrimethylammonium permanganate / CH2Cl2 / 5 h / Ambient temperature
View Scheme
n-tetradecanoic acid
544-63-8

n-tetradecanoic acid

glycerol
56-81-5

glycerol

A

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

B

glycerol 1,3-dimyristate
7770-09-4

glycerol 1,3-dimyristate

Conditions
ConditionsYield
With Penicillium camembertii lipase immobilized on epoxy SiO2-PVA at 45 - 65℃; Enzymatic reaction;
n-tetradecanoic acid
544-63-8

n-tetradecanoic acid

glycerol
56-81-5

glycerol

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
With immobilized Candida antarctica Lipase B; 3-dodecyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate In tert-butyl alcohol at 60℃; Molecular sieve; Green chemistry; Enzymatic reaction;
C34H64O8Si

C34H64O8Si

1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

Conditions
ConditionsYield
With water at 50℃; for 4h;
1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

butylboronic acid
4426-47-5

butylboronic acid

2-butyl-4-tetradecanoyloxymethyl-[1,3,2]dioxaborolane
18885-80-8

2-butyl-4-tetradecanoyloxymethyl-[1,3,2]dioxaborolane

Conditions
ConditionsYield
In acetone
1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

phenylboronic acid
98-80-6

phenylboronic acid

2-phenyl-4-tetradecanoyloxymethyl-[1,3,2]dioxaborolane
18885-84-2

2-phenyl-4-tetradecanoyloxymethyl-[1,3,2]dioxaborolane

Conditions
ConditionsYield
In acetone
1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

pyridine-3-carbonyl chloride hydrochloride
20260-53-1

pyridine-3-carbonyl chloride hydrochloride

2,3-dinicotinoyl-1-tetradecanoyl-rac-glycerol

2,3-dinicotinoyl-1-tetradecanoyl-rac-glycerol

Conditions
ConditionsYield
With pyridine Ambient temperature;
1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

O2,O3-diacetyl-tartaric acid anhydride
122376-19-6

O2,O3-diacetyl-tartaric acid anhydride

2,3-diacetoxy-succinic acid mono-(2-hydroxy-3-tetradecanoyloxy-propyl) ester

2,3-diacetoxy-succinic acid mono-(2-hydroxy-3-tetradecanoyloxy-propyl) ester

Conditions
ConditionsYield
at 110 - 140℃; Acylation;
1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

C20H39O5PS

C20H39O5PS

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: dmap; triethylamine / dichloromethane / 17 h / 20 °C
2: tetrafluoroboric acid / hexane; dichloromethane / 2.5 h / 0 - 20 °C
3: tetrabutyl ammonium fluoride / tetrahydrofuran / 2 h / 20 °C
4: 5-(ethylsulfanyl)-2H-tetrazole / dichloromethane / 2 h / 20 °C
View Scheme
1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

C20H39O4PS2

C20H39O4PS2

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: dmap; triethylamine / dichloromethane / 17 h / 20 °C
2: tetrafluoroboric acid / hexane; dichloromethane / 2.5 h / 0 - 20 °C
3: tetrabutyl ammonium fluoride / tetrahydrofuran / 2 h / 20 °C
4: 5-(ethylsulfanyl)-2H-tetrazole / dichloromethane / 2 h / 20 °C
View Scheme
1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

1-myristoyl-2-methoxy-glycerol-3-(2-thio-1,3,2-oxathiaphospholane)
1232676-47-9

1-myristoyl-2-methoxy-glycerol-3-(2-thio-1,3,2-oxathiaphospholane)

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: dmap; triethylamine / dichloromethane / 17 h / 20 °C
2: tetrafluoroboric acid / hexane; dichloromethane / 2.5 h / 0 - 20 °C
3: tetrabutyl ammonium fluoride / tetrahydrofuran / 2 h / 20 °C
4: 5-(ethylsulfanyl)-2H-tetrazole / dichloromethane / 2 h / 20 °C
5: sulfur / dichloromethane / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: triethylamine; dmap
2: tetrafluoroboric acid / dichloromethane
3: tetrabutyl ammonium fluoride / tetrahydrofuran
4: 5-(ethylthio)-1H-tetrazole; sulfur / dichloromethane
View Scheme
1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

C20H39O4PS3
1232676-52-6

C20H39O4PS3

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: dmap; triethylamine / dichloromethane / 17 h / 20 °C
2: tetrafluoroboric acid / hexane; dichloromethane / 2.5 h / 0 - 20 °C
3: tetrabutyl ammonium fluoride / tetrahydrofuran / 2 h / 20 °C
4: 5-(ethylsulfanyl)-2H-tetrazole / dichloromethane / 2 h / 20 °C
5: sulfur / dichloromethane / 20 °C
View Scheme
Multi-step reaction with 4 steps
1: triethylamine; dmap
2: tetrafluoroboric acid / dichloromethane
3: tetrabutyl ammonium fluoride / tetrahydrofuran
4: sulfur / dichloromethane
View Scheme
1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

C21H40NO6PS
1232676-57-1

C21H40NO6PS

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: dmap; triethylamine / dichloromethane / 17 h / 20 °C
2: tetrafluoroboric acid / hexane; dichloromethane / 2.5 h / 0 - 20 °C
3: tetrabutyl ammonium fluoride / tetrahydrofuran / 2 h / 20 °C
4: 5-(ethylsulfanyl)-2H-tetrazole / dichloromethane / 2 h / 20 °C
5: sulfur / dichloromethane / 20 °C
6: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1 h / 20 °C
View Scheme
1-monoglyceride myristic acid
589-68-4

1-monoglyceride myristic acid

C21H40NO5PS2
1232676-62-8

C21H40NO5PS2

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: dmap; triethylamine / dichloromethane / 17 h / 20 °C
2: tetrafluoroboric acid / hexane; dichloromethane / 2.5 h / 0 - 20 °C
3: tetrabutyl ammonium fluoride / tetrahydrofuran / 2 h / 20 °C
4: 5-(ethylsulfanyl)-2H-tetrazole / dichloromethane / 2 h / 20 °C
5: sulfur / dichloromethane / 20 °C
6: 1,8-diazabicyclo[5.4.0]undec-7-ene / dichloromethane / 1 h / 20 °C
View Scheme

589-68-4Relevant academic research and scientific papers

High-selectivity synthesis method of long-chain fatty acid monoglyceride

-

Paragraph 0027; 0030, (2019/02/27)

The invention belongs to the field of fatty acid and synthetic fatty acid glycerides and relates to a high-selectivity synthesis method of long-chain fatty acid monoglyceride, in particular to a high-selectivity synthesis method of long-chain fatty acid and synthetic fatty acid glycerides. The method comprises the steps that tetraethyl silicate and glycerin are subjected to alcoholysis reaction, and part of glycerin is esterified to generate glyceryl silicate; then the glyceryl silicate is subjected to esterification reaction with fatty acid to generate fatty acid glyceride; finally the high activity (instability) of silicate ester is utilized to achieve hydrolysis under mild conditions to synthesize the synthetic fatty acid glyceride at high selectivity. A by-product is safe and harmlessSiO2. Accordingly, the product with high monoglyceride content is obtained by using a simple process under mild conditions.

Biochemical characterization of the PHARC-associated serine hydrolase ABHD12 reveals its preference for very-long-chain lipids

Joshi, Alaumy,Shaikh, Minhaj,Singh, Shubham,Rajendran, Abinaya,Mhetre, Amol,Kamat, Siddhesh S.

, p. 16953 - 16963 (2018/11/21)

Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC) is a rare genetic human neurological disorder caused by null mutations to the Abhd12 gene, which encodes the integral membrane serine hydrolase enzyme ABHD12. Although the role that ABHD12 plays in PHARC is understood, the thorough biochemical characterization of ABHD12 is lacking. Here, we report the facile synthesis of mono-1-(fatty)acyl-glycerol lipids of varying chain lengths and unsaturation and use this lipid substrate library to biochemically characterize recombinant mammalian ABHD12. The substrate profiling study for ABHD12 suggested that this enzyme requires glycosylation for optimal activity and that it has a strong preference for very-long-chain lipid substrates. We further validated this substrate profile against brain membrane lysates generated from WT and ABHD12 knockout mice. Finally, using cellular organelle fractionation and immunofluorescence assays, we show that mammalian ABHD12 is enriched on the endoplasmic reticulum membrane, where most of the very-long-chain fatty acids are biosynthesized in cells. Taken together, our findings provide a biochemical explanation for why very-long-chain lipids (such as lysophosphatidylserine lipids) accumulate in the brains of ABHD12 knockout mice, which is a murine model of PHARC.

Monomyristin and monopalmitin derivatives: Synthesis and evaluation as potential antibacterial and antifungal agents

Jumina,Nurmala, Asma,Fitria, Anggit,Pranowo, Deni,Sholikhah, Eti Nurwening,Kurniawan, Yehezkiel Steven,Kuswandi, Bambang

, (2018/12/11)

In the present work, monoacylglycerol derivatives, i.e., 1-monomyristin, 2-monomyristin, and 2-monopalmitin were successfully prepared from commercially available myristic acid and palmitic acid. The 1-monomyristin compound was prepared through a transesterification reaction between ethyl myristate and 1,2-O-isopropylidene glycerol, which was obtained from the protection of glycerol with acetone, then followed by deprotection using Amberlyst-15. On the other hand, 2-monoacylglycerol derivatives were prepared through enzymatic hydrolysis of triglycerides in the presence of Thermomyces lanuginosa lipase enzymes. The synthesized products were analyzed using fourier transform infrared (FTIR) spectrophotometer, gas or liquid chromatography-mass spectrometer (GC-MS or LC-MS), and proton and carbon nuclear magnetic resonance (1H- and13C-NMR) spectrometers. It was found that monomyristin showed high antibacterial and antifungal activities, while 2-monopalmitin did not show any activity at all. The 1-monomyristin compound showed higher antibacterial activity against Staphylococcus aureus and Aggregatibacter actinomycetemcomitans and also higher antifungal activity against Candida albicans compared to the positive control. Meanwhile, 2-monomyristin showed high antibacterial activity against Escherichia coli. The effect of the acyl position and carbon chains towards antibacterial and antifungal activities was discussed.

Highly selective biocatalytic synthesis of monoacylglycerides in sponge-like ionic liquids

Lozano, Pedro,Gomez, Celia,Nieto, Susana,Sanchez-Gomez, Gregorio,García-Verdugo, Eduardo,Luis, Santiago V.

, p. 390 - 396 (2017/08/14)

The biocatalytic synthesis of monoacylglycerides (MAGs) was carried out by the direct esterification of fatty acids (i.e. capric, lauric, myristic, palmitic and oleic acids, respectively) with glycerol in different ionic liquids (ILs) based on cations with long alkyl side-chains (e.g. 1-hexadecyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide [C16mim][NTf2], 1-dodecyl-3-methylimidazolium tetrafluoroborate [C12mim][BF4], etc.). Although all ILs have been shown as suitable reaction media for Novozym 435-catalyzed esterification of glycerol with free fatty acids, a high selectivity of MAGs was only observed in the [C12mim][BF4] case (e.g. up to 100% selectivity and 100% yield for monolaurin). Furthermore, as these ILs are temperature switchable ionic liquid/solid phases that behave as sponge-like systems, a straightforward protocol for IL-free MAG recovery, based on iterative centrifugations at controlled temperature, has been developed.

The chemical synthesis and preliminary biological studies of phosphodiester and phosphorothioate analogues of 2-methoxy-lysophosphatidylethanolamine

Sowińska, Agata,Rytczak, Przemys?aw,Gendaszewska-Darmach, Edyta,Drzazga, Anna,Kozio?kiewicz, Maria,Okruszek, Andrzej

, p. 3725 - 3729 (2016/07/21)

The chemical synthesis of phosphorothioate/phosphodiester analogues of 2-methoxy-lysophosphatidylethanolamine has been described. For the preparation of phosphorothioate derivatives oxathiaphospholane approach has been employed. The phosphodiester compounds were prepared by OXONE oxidation of corresponding phosphorothioates. Each lysophospholipid analogue was synthesized as a series of four compounds, bearing different fatty acid residues both saturated (14:0, 16:0, 18:0) and unsaturated (18:1). The methylation of glycerol 2-hydroxyl function was applied in order to increase the stability of prepared analogues by preventing 1→2 acyl migration. The cytotoxicity of newly synthesized 2-methoxy-lysophosphatidylethanolamine derivatives was evaluated with resazurin-based method in prostate cancer PC3 cell line. The highest reduction of cell viability was noted for LPE analogues containing myristoyl acyl chain.

The chemical synthesis and cytotoxicity of new sulfur analogues of 2-methoxy-lysophosphatidylcholine

Rytczak, Przemyslaw,Drzazga, Anna,Gendaszewska-Darmach, Edyta,Okruszek, Andrzej

, p. 6794 - 6798 (2014/01/06)

The chemical synthesis of phosphorothioate/phosphorodithioate analogues of 2-methoxy-lysophosphatidylcholine has been described. For the preparation of new sulfur derivatives of lysophosphatidylcholine both oxathiaphospholane and dithiaphospholane approaches have been employed. Each lysophospholipid analogue was synthesized as a series of five compounds, bearing different fatty acid residues both saturated (12:0, 14:0, 16:0, 18:0) and unsaturated (18:1). The methylation of glycerol 2-hydroxyl function was applied in order to increase the stability of prepared analogues by preventing 1→2 acyl migration. The cellular toxicity of newly synthesized 2-methoxy-lysophosphatidylcholine derivatives was measured using MTT viability assay and lactate dehydrogenase release method.

The chemical synthesis of metabolically stabilized 2-OMe-LPA analogues and preliminary studies of their inhibitory activity toward autotaxin

Gendaszewska-Darmach, Edyta,Laska, Edyta,Rytczak, Przemys?aw,Okruszek, Andrzej

supporting information; body text, p. 2698 - 2700 (2012/05/20)

The chemical synthesis of five new metabolically stabilized 2-OMe-LPA analogues (1a-e) possessing different fatty acid residues has been performed by phosphorylation of corresponding 1-O-acyl-2-OMe-glycerols which were prepared by multistep process from racemic glycidol. The now analogues were subjected to biological characterization as autotaxin inhibitors using the FRET-based, synthetic ATX substrate FS-3. Among tested compounds 1-O-oleoyl-2-OMe-LPA (1e) appeared to be the most potent, showing ATX inhibitory activity similar to that of unmodified 1-O-oleoyl-LPA. Parallel testing showed, that similar trend was also observed for corresponding 1-O-acyl-2-OMe-phosphorothioates (2a-e, synthesized as described by us previously). 1-O-oleoyl-2-OMe-LPA (1e) was found to be resistant toward alkaline phosphatase as opposed to unmodified 1-O-oleoyl-LPA.

Enzymatic synthesis of monoglycerides by esterification reaction using Penicillium camembertii lipase immobilized on epoxy SiO2-PVA composite

Freitas, Larissa,Paula, Ariela V.,dos Santos, Julio C.,Zanin, Gisella M.,de Castro, Heizir F.

experimental part, p. 87 - 90 (2010/10/19)

Glycerol-fatty acid esterification has been conducted with lipase from Penicillium camembertii lipase immobilized on epoxy SiO2-PVA in solvent-free media, with the major product being 1-monoglyceride, a useful food emulsifier. For a given set of initial conditions, the influence of reaction was measured in terms of product formation and selectivity using different fatty acids as acyl donors. Results were found to be relatively dependent of the chain length of the fatty acids, showing high specificity for both myristic and palmytic acids attaining final mixture that fulfills the requirements established by the World Health Organization to be used as food emulsifiers.

Preparation of diacid 1,3-diacylglycerols

Craven, R. John,Lencki, Robert W.

, p. 1281 - 1291 (2011/08/21)

A complete methodology (including synthesis, purification and analysis) for the preparation of 1,3-DAG is described. For a successful synthesis project, the strengths and weaknesses of each particular process should be taken into account and measures taken to offset or balance potential weaknesses. To this end, we describe some of the challenges associated with: chemically and enzymatically catalyzed acylglycerol syntheses; recrystallization and flash chromatography for purification of partial acylglycerols; and thin-layer chromatography (TLC) separation of DAG. For this work, 1-MAG intermediates and subsequent diacid 1,3-DAG were prepared using non-enzymatic methods, whereas, monoacid 1,3-DAG were prepared by enzymatic methods. It was not always possible to obtain pure samples of target compounds-in recrystallizations this is due to solid solution formation and co-crystallization and in chromatographic separations it is due to co-elution of components with similar Rf. Furthermore, TLC Rf of DAG is determined by two main factors: acyl chain length and positional isomerism. Interestingly, while the role of positional isomerism is well-known, the role of acyl chain length in these separations has only recently come to light.

The chemical synthesis of phosphorothioate and phosphorodithioate analogues of lysophosphatidic acid (LPA) and cyclic phosphatidic acid (CPA)

Rytczak, Przemyslaw,Koziolkiewicz, Maria,Okruszek, Andrzej

experimental part, p. 1008 - 1017 (2010/08/05)

The chemical synthesis of new sulfur analogues of lysophospholipids has been described, including phosphorothioate/phosphorodithioate derivatives of lysophosphatidic acids (LPA) and phosphorothioate/phosphorodithioate derivatives of cyclic phosphatidic acids (cPA). For the preparation of LPA and cPA derivatives both oxathiaphospholane and dithiaphospholane approaches have been employed. Each lysophospholipid analogue has been synthesized as a series of five compounds, bearing five different fatty acid residues, both saturated (12:0, 14:0, 16:0, 18:0) and unsaturated (18:1), in the form of ammonium salts. The phosphorodithioate analogues of LPA were obtained as triethylammonium salts, however these were not stable and decomposed when transformed into the ammonium salt by ion exchange in aqueous methanol solution. The new sulfur analogues of LPA and cPA may share interesting biological properties of their parent compounds, and previously synthesized derivatives may behave as regulators of many metabolic processes and hopefully show new biological activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 589-68-4